Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers

Mostrar otras versiones (1)

The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for safe and effective vaccines to be rapidly developed and distributed worldwide, especially considering the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Protein subunit vaccines hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad S., Kim, Eun, Le Hingrat, Quentin, Kleinman, Adam, Ferrari, Alessandro, Sammartino, Jose C., Percivalle, Elena, Xu, Cuiling, Huang, Shaohua, Kenniston, Thomas W., Cassaniti, Irene, Baldanti, Fausto, Pandrea, Ivona, Gambotto, Andrea, Apetrei, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653869/
https://www.ncbi.nlm.nih.gov/pubmed/37830800
http://dx.doi.org/10.1128/mbio.02070-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653869/
https://www.ncbi.nlm.nih.gov/pubmed/37830800
http://dx.doi.org/10.1128/mbio.02070-23

Ejemplares similares